QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Quantify at WCO-IOF-ESCEO 2018
Quantify will be represented at this year’s WCO-IOF-ESCEO congress (the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases) by Fredrik Borgström and Gustaf Ortsäter. The posters “Prior Fracture Cascade and Incidence of Imminent Fracture After Fragility Fracture in a Swedish Database Study”, co-authored by Quantify’s Jonas Banefelt and Gustaf Ortsäter, and “Long-Term Cost-Effectiveness of Screening for Fracture Risk in a UK Primary Care Setting”, co-authored […]
The two V’s of model quality control: Validation and verification
In the world of market access, a large amount of resources go into engineering all-singing, all-dancing global models with a clean look and friendly user interface while simultaneously providing value to local affiliates. Although this feat is certainly an accomplishment, it is important to remember the importance of model quality control (QC). This activity is a core component of model development and reduces the risk of errors that can […]
Quantify at the Future of Swedish and Danish Life Science conference
Quantify’s Josefine Röhss and Hanna Fues-Wahl will be attending the Future of Swedish and Danish Life Science conference in Lund, Sweden, 22nd of March. We hope to see you there!
Poster co-authored by Quantify presented at ACC.18
The poster “Recurrent Cardiovascular Event Rates in High-Risk Atherosclerotic Cardiovascular Disease Patients: Estimates from Swedish Population-Based Register Data” co-authored by Maria Lindh, Jonas Banefelt and Sara Hallberg of Quantify, was presented at The American College of Cardiology 67th Annual Scientific Session & Expo, held in Orlando, Florida, March 10-12.